A review on targeted therapies for lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Egile nagusia: | Ashraf, Anushey |
---|---|
Beste egile batzuk: | Khan, Tanisha Tabassum Sayka |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2023
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/19353 |
Antzeko izenburuak
-
Immunotherapy in the Management of Lung Cancer
nork: Tasnim, Humayra
Argitaratua: (2022) -
Potential of liposomes for the treatment of lung cancer- a review
nork: Mim, Shanzida
Argitaratua: (2023) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
nork: Tania, Umme
Argitaratua: (2023) -
Molecules associated with the development of lung cancer
nork: Rahman, Adree, et al.
Argitaratua: (2023) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
nork: Paul, Pulock
Argitaratua: (2024)